← Open Payments lookup

MIA STANCIL: Open Payments

NPI 1649902156 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,236 in 57 payments from 18 companies in 2025. Trend: 2023 $385 · 2024 $1,001 · 2025 $1,236

Food & beverage: $1,236
CompanyPaymentsAmount
Novo Nordisk Inc10$169
Dexcom, Inc.2$149
AstraZeneca Pharmaceuticals LP6$144
Lilly USA, LLC8$136
Novartis Pharmaceuticals Corporation5$117
SANOFI-AVENTIS U.S. LLC5$98
Amgen Inc.3$68
Bayer Healthcare Pharmaceuticals Inc.3$53
GlaxoSmithKline, LLC.3$49
Exact Sciences Corporation2$43

Products named: DEXCOM G7 GSS (161), LEQVIO, MOUNJARO, TZIELD, Wegovy, FARXIGA, Kerendia, Ozempic.

Industry payments across GA — which companies pay providers there.